Tom Mitchell
Tom Mitchell studied medicine at Oxford University before training in urology in the East of England (2011-2018). He was awarded Fellowship of the Royal College of Surgeons in 2018. He now practices as a Consultant Urologist at Addenbrooke’s Hospital, where he specialises in the surgical management of patients with kidney cancer.
His scientific training includes a DPhil in Engineering Science from Oxford University. During his clinical training he held an Academic Clinical Lectureship at Cambridge University (2014-2018). In 2018 he was awarded a Cancer Research UK Clinical Scientist Fellowship at the Wellcome Sanger Institute, prior to becoming a Group Leader in the Early Cancer Institute in 2023.
His group aims to improve outcomes for patients with urological malignancies through developing clinically useful methods to predict tumour behaviour, and implementing strategies to prevent incurable disease. In October 2024 Tom was appointed as the Krishnan-Ang Distinguished Group Leader in the Urological Malignancies Virtual Institute (UMVI). His appointment was funded through a generous donation by the Krishnan-Ang Foundation to Trinity College.
Sessions
-
Using AI and Spatial Multiomics to Decode Tumour Evolution and Identify High-Risk Cancer27-Jan-2027Spatial Stage